Health & Safety Industry Today

United States Immunoassay Market is Growing at a CAGR of 8.00% During the Forecast Period 2024-2032

The escalating demand for immunoassays in the food and beverage (F&B) industry to detect contaminants, allergens, and pathogens and ensure the safety and quality of food products currently represents one of the major factors influencing the market positively in the United States.
Published 22 April 2024

The latest report by IMARC Group, titled “United States Immunoassay Market Report by Technology (Radioimmunoassay, Enzyme Immunoassay, Rapid Test, and Others), Product (Reagents and Kits, Analyzers/Instruments, Software and Services), Application (Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, and Others), End Use (Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical and Biotech Companies, Academic Research Centers, and Others), and Region 2024-2032” The study provides a detailed analysis of the industry, including the United States Immunoassay market forecast, size, share, trends, price and growth. The market size is projected to exhibit a growth rate (CAGR) of 8.00% during 2024-2032. 

United States Immunoassay Market Trends:

Immunoassays are biochemical tests that rely on the specificity of an antibody-antigen reaction to detect and quantify substances in a sample. The principle behind immunoassays involves an antigen binding to an antibody to form a stable complex, which can then be measured to infer the amount of antigen in the sample. This method is crucial for clinical diagnostics, drug development, and environmental monitoring. Immunoassay technologies range from traditional radioimmunoassays (RIA) and enzyme-linked immunosorbent assays (ELISA) to advanced multiplex assays and chemiluminescence immunoassays (CLIA). These tests can identify a wide array of biomolecules, including hormones, proteins, peptides, and drugs, making them indispensable in medical laboratories. The sensitivity and specificity of immunoassays make them highly effective for early disease detection, therapeutic monitoring, and ensuring the safety of blood and blood products. Furthermore, ongoing advancements in immunoassay technology are enhancing their accuracy and speed, enabling rapid on-site testing, which is vital for timely clinical decisions.

The United States immunoassay market is witnessing significant growth, driven by the rising prevalence of chronic and infectious diseases, which necessitates robust diagnostic solutions. The aging population, a primary consumer of continuous monitoring and testing, is another critical factor propelling this market. As diseases like cancer, diabetes, and cardiovascular conditions surge, the demand for accurate and early detection through immunoassays intensifies. Technological advancements such as automation and high-throughput systems are setting trends in the immunoassay market by increasing the efficiency and throughput of diagnostic tests, thus supporting high-volume labs in delivering faster results. The integration of artificial intelligence and machine learning in immunoassay platforms is optimizing test analyses and enhancing result precision, contributing further to market expansion. Moreover, the ongoing COVID-19 pandemic has underscored the importance of rapid testing, which in turn has boosted investments in research and development of novel immunoassay tests across the United States.

Additionally, government initiatives aimed at improving healthcare infrastructure and increasing healthcare spending are favorably impacting the immunoassay market. With these drivers, coupled with growing awareness about preventive healthcare and an increase in healthcare expenditure by the private and public sectors, the immunoassay market in the United States is set to continue its growth trajectory, promising extensive opportunities for market players in the foreseeable future.

For an in-depth analysis, you can request the sample copy of the market report:

United States Immunoassay Market Segmentation:

Technology Insights:

  • Radioimmunoassay
  • Enzyme Immunoassay
  • Rapid Test
  • Others

Product Insights:

  • Reagents and Kits
  • Analyzers/Instruments
  • Software and Services

Application Insights:

  • Therapeutic Drug Monitoring
  • Oncology
  • Cardiology
  • Endocrinology
  • Infectious Disease Testing
  • Autoimmune Diseases
  • Others

End Use Insights:

  • Hospitals
  • Blood Banks
  • Clinical Laboratories
  • Pharmaceutical and Biotech Companies
  • Academic Research Centers
  • Others

Regional Insights:

  • Northeast 
  • Midwest 
  • South 
  • West

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Ask analyst for your customized sample:

Browse more research report:

United States Modular Construction Market

United States Logistics Automation Market

Vietnam Luxury Watch Market

India PET Bottle Market

India RegTech Market

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:


134 N 4th St. Brooklyn, NY 11249, USA


Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-216

Other Industry News

Ready to start publishing

Sign Up today!